Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 14.50
0.00 (0.00%)
At close: Dec 5, 2025
Fusion Antibodies Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 1.6 | 1.97 | 1.14 | 2.9 | 4.8 | 4.17 | Upgrade
|
| Revenue Growth (YoY) | -11.43% | 72.97% | -60.84% | -39.55% | 15.22% | 6.93% | Upgrade
|
| Cost of Revenue | 1.24 | 1.54 | 1.18 | 2.33 | 2.33 | 2.14 | Upgrade
|
| Gross Profit | 0.35 | 0.43 | -0.05 | 0.57 | 2.47 | 2.02 | Upgrade
|
| Selling, General & Admin | 1.92 | 2.05 | 2 | 3.13 | 3.03 | 2.74 | Upgrade
|
| Research & Development | 0.18 | - | - | - | - | - | Upgrade
|
| Other Operating Expenses | -0.37 | - | -0.01 | -0.01 | -0.03 | -0.19 | Upgrade
|
| Operating Expenses | 1.82 | 2.16 | 2.23 | 3.47 | 3.79 | 3.27 | Upgrade
|
| Operating Income | -1.47 | -1.73 | -2.27 | -2.89 | -1.33 | -1.25 | Upgrade
|
| Interest Expense | -0.01 | -0 | -0.01 | -0 | -0.01 | -0.02 | Upgrade
|
| Interest & Investment Income | 0 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.05 | -0.05 | -0.02 | 0.04 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1.53 | -1.78 | -2.29 | -2.86 | -1.33 | -1.26 | Upgrade
|
| Pretax Income | -1.53 | -1.78 | -2.29 | -2.86 | -1.33 | -1.26 | Upgrade
|
| Income Tax Expense | -0.07 | -0.06 | -0.06 | -0.26 | -0.13 | 1.64 | Upgrade
|
| Net Income | -1.47 | -1.71 | -2.23 | -2.6 | -1.2 | -2.9 | Upgrade
|
| Net Income to Common | -1.47 | -1.71 | -2.23 | -2.6 | -1.2 | -2.9 | Upgrade
|
| Shares Outstanding (Basic) | 105 | 96 | 56 | 26 | 26 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 105 | 96 | 56 | 26 | 26 | 25 | Upgrade
|
| Shares Change (YoY) | 31.30% | 72.58% | 113.55% | 0.27% | 1.91% | 15.24% | Upgrade
|
| EPS (Basic) | -0.01 | -0.02 | -0.04 | -0.10 | -0.05 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.02 | -0.04 | -0.10 | -0.05 | -0.11 | Upgrade
|
| Free Cash Flow | -1.25 | -1.37 | -1.77 | -1.87 | -0.59 | -1.5 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.07 | -0.02 | -0.06 | Upgrade
|
| Gross Margin | 22.05% | 21.88% | -3.96% | 19.79% | 51.39% | 48.59% | Upgrade
|
| Operating Margin | -92.23% | -87.84% | -200.00% | -99.76% | -27.61% | -29.99% | Upgrade
|
| Profit Margin | -91.92% | -87.18% | -195.95% | -89.49% | -25.00% | -69.60% | Upgrade
|
| Free Cash Flow Margin | -78.26% | -69.92% | -155.90% | -64.39% | -12.25% | -36.04% | Upgrade
|
| EBITDA | -1.4 | -1.62 | -2.05 | -2.55 | -0.65 | -0.61 | Upgrade
|
| EBITDA Margin | -87.59% | -82.65% | -180.81% | -87.80% | -13.48% | -14.60% | Upgrade
|
| D&A For EBITDA | 0.07 | 0.1 | 0.22 | 0.35 | 0.68 | 0.64 | Upgrade
|
| EBIT | -1.47 | -1.73 | -2.27 | -2.89 | -1.33 | -1.25 | Upgrade
|
| EBIT Margin | -92.23% | -87.84% | -200.00% | -99.76% | -27.61% | -29.99% | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.